Sign in

CIK 0001175680 · Non-accelerated filer<br>Smaller reporting company

CytoDyn Inc.

Sign in to watch
Ticker
CYDY
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
May 31
Incorporated
DE
Entity type
operating
EIN
753056237
Phone
360-980-8524
Business address
1111 MAIN STREET, SUITE 660, VANCOUVER, WA, 98660
Former names
CYTODYN INC, REXRAY CORP
  1. 4/A Open-market sale Chief Financial Officer sold 1,104,799 shares at an average $5.27 ($5,827,032)
  2. 4 Open-market sale Chief Financial Officer sold 1,108,799 shares at an average $5.28 ($5,849,360)
  3. S-3 Offering Registration Statement
  4. D Other Notice of Sales of Unregistered Securities
  5. D Other Notice of Sales of Unregistered Securities
  6. 8-K Event Material agreement · New debt or obligation · Unregistered share sale
  7. 4 Open-market buy Director bought 193,500 shares at $2.57 ($497,295)
  8. 4 Open-market buy GC and Corporate Secretary bought 10,000 shares at $2.50 ($25,000)
  9. 4 Open-market buy Director bought 120,000 shares at $2.49 ($298,308)
  10. 4 Grant or award Chief Scientific Officer acquired 200,000 shares (grant or award)
  11. 3 Insider Initial Statement of Ownership
  12. 10-Q Report Quarterly Report
  13. 4 Grant or award GC and Corporate Secretary acquired 70,000 shares (grant or award)
  14. 4 Grant or award Chief Technology Officer acquired 200,000 shares (grant or award)
  15. 4 Grant or award Chief Financial Officer acquired 100,000 shares (grant or award)
  16. 4 Grant or award Chairman & CMO acquired 250,000 shares (grant or award)
  17. 4 Grant or award President & CEO acquired 500,000 shares (grant or award)
  18. 8-K Event Executive or director change · Shareholder vote results
  19. S-8 Other Securities Offered to Employees in Benefit Plans
  20. 8-K Event Regulation FD disclosure

Page 24 of 71 · 1,401 filings